Filter
3338
Filtered Results: 3338
Text search:
burden
of
illness
Featured
Recommendations
306
New Publications
899
Language
Document type
No document type
1966
Studies & Reports
588
Guidelines
382
Manuals
148
Strategic & Response Plan
122
Training Material
47
Fact sheets
45
Situation Updates
19
Infographics
8
Resource Platforms
7
Brochures
6
Countries / Regions
India
170
Global
157
Kenya
116
South Africa
94
Ethiopia
79
Nigeria
70
Western and Central Europe
68
Uganda
66
Liberia
64
Nepal
62
Sierra Leone
55
Tanzania
54
Malawi
53
Africa
50
Zambia
47
Bangladesh
47
Ghana
43
Namibia
43
Latin America and the Carribbean
43
Rwanda
38
Myanmar / Burma
31
Syria
28
Ukraine
28
South–East Asia Region
26
Philippines
25
Lesotho
22
Eastern Europe
22
Cambodia
21
Mozambique
20
Zimbabwe
19
Asia
19
Congo, Democratic Republic of
15
South Sudan
15
Botswana
15
East and Southern Africa
15
Guinea
14
Germany
14
Indonesia
13
Eastern Europe and Central Asia
13
USA
12
Eswatini/ Swaziland
12
Russia
11
West and Central Africa
10
Haiti
9
Pakistan
9
Burkina Faso
8
Jordan
7
Afghanistan
7
Thailand
7
Sudan
7
Western Pacific Region
7
Cameroon
6
Brazil
6
Colombia
6
Yemen
6
Middle East and North Africa
6
Venezuela
6
Senegal
5
Albania
5
Vietnam
5
Somalia
4
Lebanon
4
China
4
Peru
4
Ecuador
4
Sri Lanka
4
Mali
3
Iraq
3
Turkey
3
Central African Republic
3
Burundi
3
Greece
3
Mexico
3
Southern Africa
3
Laos
3
Canada
3
Timor Leste/ East Timor
3
Tajikistan
3
Moldova
3
North America
3
Jamaica
3
Mauritius
3
Egypt
2
Gambia
2
Papua New Guinea
2
Angola
2
Guatemala
2
Palestine
2
Romania
2
Kazakhstan
2
Georgia
2
Belarus
2
Côte d’Ivoire / Ivory Coast
1
Togo
1
Ireland
1
Benin
1
Hungary
1
Honduras
1
Chile
1
Other region
1
Paraguay
1
Poland
1
Mongolia
1
Bulgaria
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Kyrgyzstan
1
Turkmenistan
1
United Kingdom
1
Authors & Publishers
Publication Years
Category
Countries
1281
Clinical Guidelines
292
Public Health
223
Women & Child Health
168
Key Resources
96
Capacity Building
53
Pharmacy & Technologies
22
Annual Report MEDBOX
1
Toolboxes
Mental Health
349
HIV
257
COVID-19
248
TB
221
Planetary Health
161
Disability
131
AMR
113
Caregiver
94
Rapid Response
84
Global Health Education
80
NCDs
69
Conflict
67
NTDs
67
Refugee
53
Ebola
49
Pharmacy
40
Natural Hazards
27
Health Financing Toolbox
22
Cholera
17
Polio
17
Social Ethics
17
Zika
12
Specific Hazards
11
South Sudan
1
This report describes findings from a telephone survey with 1,316 people conducted in February 2021. The survey examined how people respond to public health and social measures (PHSMs) to prevent COVID-19. The sample is representative of households ...
Pregnancy and childbirth during adolescence profoundly affects the lives of millions of girls worldwide, and is a leading cause of maternal mortali...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform pra...
Available in Chinese, English, French, Russian and Spanish; WHO and UNICEF policy brief, 19 April 2021
Persons with disabilities are disproportionately impacted by COVID-19, both directly because of infection, and indirectly because ... restrictions to reduce the spread of the virus. Persons with disabilities are a diverse group, and the risks, barriers and impacts faced by them will vary in different contexts according to, among other factors, their age, gender identity, type of disability, ethnicity, sexual orientation, and migration status.
This document presents considerations and actions for the following stakeholders to ensure equity in access to vaccination against COVID‑19 for persons with disabilities
Biodiversity and Health in the Face of Climate Change pp 47–66
This chapter reviews the emerging importance of pollen allergies in relation to ongoing climate change. Allergic diseases have been ...
This Topic Guide has been compiled to provide an overview of undernutrition in the context of development. The focus of the Guide is on undernutrit...
This World Health Organization (WHO) and the International Labour Organization (ILO) joint guidelines production aims at harnessing the contribution of employers and workers towards the control of T...
The Wits Justice Project
HIV Nursing Matters / page 30-33 / June 2015
Source: Guidelines for the Prevention and Treatment of HIV in Arrested, Detained and Sentenced Persons, 2008.
During the past five decades, the incidence of dengue has increased 30-fold. Some 50–100 million new infections are estimated to occur annually in more than 100 endemic countries, with a documented further spread to previously unaffected areas; e...
22 July 2022. This document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Available in Arabic, Chinese, English, French, Russian and Spanish. You can download a summary of the main report and background documents!
The report demonstrates that the current system—at both national and international levels— was not adeq...
2nd edition. The purpose of the WHO human health risk assessment toolkit: chemical hazards is to provide its users with guidance to identify, acquire and use the information needed to assess chemical hazards, exposures and the corresponding health r...
The strategy recommends that AU Member States should enhance, where feasible, existing COVID-19 surveillance to include:
Community-based surveillance to detect symptomatic cases early for treatment and to avert viral transmission;
Sentinel surveillance in high-risk populations to detect ...
The mhGAP community toolkit: field test version is an integral part of WHO's Mental Health Gap Action Programme (mhGAP), and aims at scaling up services for people with mental health conditions to achieve universal health coverage.
The toolkit p...
This sourcebook aims to detail why health needs to be part of urban and territorial planning and how to make this happen. It brings together two vital elements we need to build habitable cities on a habitable planet: 1) Processes to guide the develo...
Background: The World Health Organization (WHO) published a clinical case definition of post COVID-19
condition, by a Delphi consensus, on 6 October 2021. That process concluded that a separate definition
may be applicable for children. It is impo...
Promoting health and preventing disease is a critical component of the effort required to achieve Universal Health Coverage (UHC). to date, efforts to achieve UHC have focused mostly on strengthening health systems and their capacities to provide cu...
The Regional Action Framework for Noncommunicable Disease Prevention and Control provides a unified vision of objectives and recommended actions to combat the noncommunicable disease (NCD) epidemic in the Western Pacific Region. Implementation...
Diphtheria is caused by Corynebacterium species, mostly by toxin-producing Corynebacterium diphtheriae and rarely by toxin-producing strains of C. ulcerans and C. pseudotuberculosis. The most common type o... diphtheria is classic respiratory diphtheria, whereby the exotoxin produced characteristically causes the formation of a pseudomembrane in the upper respiratory tract and damages other organs, usually the myocardium and peripheral nerves. Acute respiratory obstruction, acute systemic toxicity, myocarditis and neurologic complications are the usual causes of death. The infection can also affect the skin (cutaneous diphtheria). More rarely, it can affect mucous membranes at other non-respiratory sites, such as genitalia and conjunctiva.
C. diphtheriae is transmitted from person to person by intimate respiratory and direct contact; in contrast, C. ulcerans and C. pseudotuberculosis are zoonotic infections, not transmitted person-to-person. The incubation period of C. diphtheriae is two to five days (range 1– 10 days). A person is infectious as long as virulent bacteria are present in respiratory secretions, usually two weeks without antibiotics, and seldom more than six weeks. In rare cases, chronic carriers may shed organisms for six months or more. Skin lesions are often chronic and infectious for longer periods. Effective antibiotic therapy (penicillin or erythromycin) promptly terminates shedding in about one or two days.
The Priority medicines for mothers and children 2011 list was updated following the 18th Expert Committee Meeting
on Selection and Use of Medicines, the release of new treatment guidelines and fee...
